The Society of the Four Arts is collaborating with the Garden Club of Palm Beach for a lecture featuring botanical genetic ...

Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability remains years away.

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

Investors have bought into the promise of CRISPR technology for years. The ability to target and edit genes to treat cancer ...

One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand treatment to others.

Researchers identified a CRISPR-based genetic mechanism that restrains the virulence of a key gum disease bacterium.

Cathie Wood’s ARK Invest added to several beaten-down technology and biotech names while trimming positions elsewhere. The investment manager made a notable purchase in gene-editing company CRISPR ...

Researchers are applying CRISPR-Cas9 as a stoichiometric binding tool to improve NGS library normalization. The ...

CRISPR Therapeutics (NASDAQ: CRSP) is a company that can potentially help revolutionize healthcare. Its gene-editing therapies can be game changers for patients living with illnesses and conditions ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 5.44% at $49.93. This move lagged the S&P 500's daily loss of 0.08%. On the other hand, the Dow registered a loss of 0.61%, and the ...